I'll add very quickly, because it goes to something I raised earlier, that the life cycle changes, and having attachments to that.... I'll give you a good example.
Vitamin K, until recently, was a prescription drug. There's a lot of history behind that. Some of the attachments to how it's sold depend on its final use. As a prescription drug, it has certain aspects with respect to post-market surveillance. If you expose that to a larger audience without the intervention of a health professional, then you can attach other kinds of post-market requirements to give you feedback. Then, as you discover that there's no increased ADR as a result of it, you can remove some of those encumbrances. So it does have a good, positive life-cycle approach when applied appropriately for the kind of product you're thinking of.